[go: up one dir, main page]

US3293261A - 1-isopropyl-3-phenyl-5-aminopyrazole - Google Patents

1-isopropyl-3-phenyl-5-aminopyrazole Download PDF

Info

Publication number
US3293261A
US3293261A US380681A US38068164A US3293261A US 3293261 A US3293261 A US 3293261A US 380681 A US380681 A US 380681A US 38068164 A US38068164 A US 38068164A US 3293261 A US3293261 A US 3293261A
Authority
US
United States
Prior art keywords
aminopyrazole
isopropyl
phenyl
ethanol
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US380681A
Inventor
Jr Harry R Snyder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Pharmacal Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Pharmacal Co filed Critical Norwich Pharmacal Co
Priority to US380681A priority Critical patent/US3293261A/en
Application granted granted Critical
Publication of US3293261A publication Critical patent/US3293261A/en
Assigned to NORWICH EATON PHARMACEUTICALS, INC., A CORP. OF OH reassignment NORWICH EATON PHARMACEUTICALS, INC., A CORP. OF OH ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: MORTON-NORWICH PRODUCTS, INC., A CORP. OF DE
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms

Definitions

  • These new pyrazole compounds possess pharmocological activity being particularly distinguished by their ability to produce skeletal muscle relaxation upon administration to animals. Thus they are useful as muscle relaxants.
  • the compounds of Formula I are readily produced. They may :be simply prepared by bringing together benzoylacetonitrile and the appropriate hydrazine, preferably in the presence of a solvent.
  • An illustrative reaction scheme is:
  • R has the significance aforestated.
  • nitrile and the hydrazine are placed in an inert reaction solvent such as ethanol and the mixture preferably subjected to the influence of heat. Upon completion of the reaction the mixture is cooled and the precipitated solid recovered in conventional fashion. Recrystallization of the obtained product may be efiected in the usual manner. Suitable recrystallization media are the lower alkanols such as ethanol and methanol.
  • the compounds of this invention are readily formulated in a variety of pharmaceutical forms of the solid or liquid type using excipients and adjuvants with which incompatability is absent.
  • Exemplary solid forms consist of magnesium stearate, sucrose, talc, stearic acid, agar pectin or acacia which may take the shape of tablets or powders.
  • Exemplary liquid forms consist of peanut oil, olive oil, sesame oil and water. The liquid forms may be dispensed in capsules or as suspensions. In the case of veterinary application, the compounds may be placed in the feed or drinking water of animals.
  • the material may be recrystallized again from methanol to yield 60 g., M.P. 95.5-96 C.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

United States Eatent 6 "ice 3,293,261 I-ISOPROPYL-3-PI-ENYL-5-AM1NOPYRAZOLE Harry R. Snyder, Jrx, Norwich, N.Y., assignor to The Norwich Pharmacal Company, Norwich, N.Y., a corporation of New York No Drawing. Filed July 6, 1964, Ser. No. 380,681 1 Claim. (Cl. 260-310) This invention relates to pyrazole compounds, particularly those of the formula:
U-C 8H5 HzNiN N wherein R is a isopropyl or 2-hydroxyethyl group.
These new pyrazole compounds possess pharmocological activity being particularly distinguished by their ability to produce skeletal muscle relaxation upon administration to animals. Thus they are useful as muscle relaxants.
The compounds of Formula I are readily produced. They may :be simply prepared by bringing together benzoylacetonitrile and the appropriate hydrazine, preferably in the presence of a solvent. An illustrative reaction scheme is:
wherein R has the significance aforestated.
In carrying out the reaction the nitrile and the hydrazine are placed in an inert reaction solvent such as ethanol and the mixture preferably subjected to the influence of heat. Upon completion of the reaction the mixture is cooled and the precipitated solid recovered in conventional fashion. Recrystallization of the obtained product may be efiected in the usual manner. Suitable recrystallization media are the lower alkanols such as ethanol and methanol.
The compounds of this invention are readily formulated in a variety of pharmaceutical forms of the solid or liquid type using excipients and adjuvants with which incompatability is absent. Exemplary solid forms consist of magnesium stearate, sucrose, talc, stearic acid, agar pectin or acacia which may take the shape of tablets or powders. Exemplary liquid forms consist of peanut oil, olive oil, sesame oil and water. The liquid forms may be dispensed in capsules or as suspensions. In the case of veterinary application, the compounds may be placed in the feed or drinking water of animals.
3 ,293,261 Patented Dec. 20, 1966 In order that this invention may be readily available to and understood by those skilled in the art the following examples are appended:
EXAMPLE I (U-788) 1-is0pr0pyl-3-phenyl-5-aminopyrazole' Benzoylaoetonitrile (94 g., 0.65 mole) and isopropylhydrazine (48 g., 0.65 mole) are placed in a flask together with ethanol. The reaction mixture is refluxed for four hours. The alcohol is removed under reduced pressure to leave a syrupy residue which slowly crystallizes. The crude material is recrystallized from a minimum amount of methanol to yield 78 g. M.P. 93-95" C.
The material may be recrystallized again from methanol to yield 60 g., M.P. 95.5-96 C.
Analysis.Calcd for C H N C, 71.61; H, 7.51; N, 20.88. Found: C, 71.43; H, 7.65
EXAMPLE II (U-768) 1- (2-hydroxyethyl) -3-phenyZ-5-aminopyrazole Benzoylacetonitrile (290 g., 2.0 moles) and 2-hydr0xyethylhydrazine (152 g., 2.0 moles) are placed in a flask together with ethanol (1000 ml.). The mixture is refluxed for four hours, cooled, and filtered to yield 297 g. (73%) of product, M.P. 147.5149.5 C. Evaporation of the filtrate followed by recrystallization of the residue aflords another 28 g. of product; total yield is 325 g. This may be recrystallized from ethanol, M.P. 149150 C.
Analysis for C H N O.Calcd: C, 65.00; H, 6.45; N, 20.68. Found: C, 65.27; H, 6.52; N, 21.11.
What is claimed is:
1-isopr0pyl-3-phenyl-5-aminopyrazole.
7 References Cited by the Examiner UNITED STATES PATENTS 2,987,523 6/1961 Staub 260-4110 2,989,539 6/1961 Anderson 26031O 3,211,743 10/ 1965 Schmidt 2603 10 OTHER REFERENCES Alberti: Gaz. Chim. Italiana, vol. 89, pages 1017-32 (1959).
Searles et al.: Jour. Org. Chem., vol. 19, page 928 (1954 WALTER A. MODANCE, Primary Examiner.
N. TROUSOF, Assistant Examiner.
US380681A 1964-07-06 1964-07-06 1-isopropyl-3-phenyl-5-aminopyrazole Expired - Lifetime US3293261A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US380681A US3293261A (en) 1964-07-06 1964-07-06 1-isopropyl-3-phenyl-5-aminopyrazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US380681A US3293261A (en) 1964-07-06 1964-07-06 1-isopropyl-3-phenyl-5-aminopyrazole

Publications (1)

Publication Number Publication Date
US3293261A true US3293261A (en) 1966-12-20

Family

ID=23502081

Family Applications (1)

Application Number Title Priority Date Filing Date
US380681A Expired - Lifetime US3293261A (en) 1964-07-06 1964-07-06 1-isopropyl-3-phenyl-5-aminopyrazole

Country Status (1)

Country Link
US (1) US3293261A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008056A1 (en) * 1978-08-10 1980-02-20 Bayer Ag N-substituted pyrazole derivatives, process for their preparation and N-hydroxyalkylpyrazoles obtained in the course of this process

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987523A (en) * 1961-06-06 Process for the production of j-methyl-
US2989539A (en) * 1961-06-20 J-amino-x-phenylpyrazoles and method
US3211743A (en) * 1965-10-12 Chj-chs-oh

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987523A (en) * 1961-06-06 Process for the production of j-methyl-
US2989539A (en) * 1961-06-20 J-amino-x-phenylpyrazoles and method
US3211743A (en) * 1965-10-12 Chj-chs-oh

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008056A1 (en) * 1978-08-10 1980-02-20 Bayer Ag N-substituted pyrazole derivatives, process for their preparation and N-hydroxyalkylpyrazoles obtained in the course of this process

Similar Documents

Publication Publication Date Title
DE2108438C2 (en) 4-(4-Methoxy-benzyl)-imidazolidin-2-one
US3254093A (en) Process for preparing pyrazoles
US3318905A (en) 1-substituted 3-dialkylaminoalkoxy-in-dazoles and 1-substituted-3-hydroxyindazoles
US3293261A (en) 1-isopropyl-3-phenyl-5-aminopyrazole
US3364227A (en) Polymethylenepyrazoles
CH441366A (en) Process for the preparation of substituted hydrazine compounds
US3178478A (en) 2-amino-5-halo-indanes
Van den Bos et al. Investigations on pesticidal phosphorus compounds I. Fungicides, insecticides and acaricides derived from 3‐amino‐1, 2, 4‐triazole
US3663564A (en) Urazoles and their production
US2483381A (en) Beta-dihydro-inylamine and the acid addition salts thereof
US3158599A (en) Nu-(arylcarbamoyl)- and nu-(arylthiocarbamoyl)-glucosamines
US2618658A (en) 2,2-dimethyl-3-hydroxypropylamine and process for its preparation
US3154543A (en) Preparation of 5-aminofurans
JPH03246282A (en) Triazolylhydrazide derivative, preparation thereof, pharmaceutical composition having said derivative as active component for treating angina pectoris or preventing stomach ulcer and preparation thereof
CH512448A (en) Process for the preparation of benzenesulfonylureas
US2970159A (en) Hydrazine derivatives
US3110728A (en) Nu-phenylacetyl-n'-acylureas
US2855400A (en) 2-methyl-pyridine-4-carboxylic acid derivatives
US3062881A (en) 1-(cycloalkanoyl)- and 1-(tri-alkyl-acetyl)-2, 2-(di-substituted)-hydrazine compounds
US3232956A (en) N-substituted-5-nitro-2-furamidines
US2877233A (en) Z-diphenyl-x-
US3072726A (en) N1-cycloalkanoyl and n1-[alpha-tri-alkyl]-alkanoyl-hydrazides and derivatives thereof
US3121113A (en) 1-benzyloxy-3-acyl-ureas
US3415933A (en) Insecticidal method and compositions comprising heterocyclic carbamic acid esters
AT266116B (en) Process for the preparation of new aliphatic α- (3-indolyl) -carboxylic acids and their salts

Legal Events

Date Code Title Description
AS Assignment

Owner name: NORWICH EATON PHARMACEUTICALS, INC., 17 EATON AVE.

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:MORTON-NORWICH PRODUCTS, INC., A CORP. OF DE;REEL/FRAME:004085/0126

Effective date: 19820609